Table 2.
Status of registered ongoing clinical trials testing different drugs and potential treatments for COVID-19.
| Drug/Treatment | aNumber of registered clinical trials | Not yet recruiting | Recruiting | Active not recruiting | Terminated | Enrolling by invitation | Withdrawn | Suspended | completed | Unknown status |
|---|---|---|---|---|---|---|---|---|---|---|
| Anakinra | 18 | 8 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Anticoagulants | 41 | 19 | 17 | 0 | 0 | 2 | 1 | 0 | 2 | 0 |
| ARB (Angiotensin Receptor Blockers) | 42 | 14 | 22 | 3 | 0 | 2 | 0 | 0 | 1 | 0 |
| Azithromycin | 93 | 35 | 44 | 5 | 1 | 1 | 1 | 5 | 1 | 0 |
| Baricitinib | 15 | 5 | 9 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Chloroquine | 73 | 28 | 35 | 2 | 0 | 3 | 1 | 2 | 2 | 0 |
| Convalescent plasma | 102 | 27 | 60 | 2 | 0 | 3 | 1 | 0 | 2 | 7 |
| Dexamethasone | 12 | 2 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Favipiravir | 24 | 13 | 8 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Heparin | 35 | 13 | 19 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| Hydroxychloroquine | 218 | 71 | 102 | 16 | 2 | 8 | 3 | 8 | 8 | 0 |
| Interferon alpha | 17 | 7 | 8 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Interferon beta | 14 | 3 | 6 | 1 | 0 | 2 | 0 | 0 | 2 | 0 |
| Interleukin 17A (IL-17A | 3 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ivermectin | 23 | 10 | 11 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Lopinavir /Ritonavir | 75 | 25 | 37 | 3 | 1 | 3 | 0 | 0 | 6 | 0 |
| Losartan | 14 | 5 | 8 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Methylprednisolone | 25 | 8 | 12 | 0 | 0 | 1 | 0 | 0 | 4 | 0 |
| Nitazoxanide | 12 | 7 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Remdesivir | 33 | 10 | 15 | 2 | 1 | 1 | 0 | 1 | 1 | 2 |
| Tocilizumab | 55 | 12 | 36 | 5 | 0 | 1 | 0 | 0 | 1 | 0 |
| Umifenovir (Arbidol) | 8 | 3 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0 |
| Vaccine | 119 | 44 | 63 | 9 | 0 | 1 | 0 | 0 | 2 | 0 |
| Vitamin C | 25 | 12 | 11 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| Vitamin D | 26 | 14 | 9 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Zinc | 15 | 10 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
Source: ClinicalTrials.gov, aacessed 13 June, 2020.